TherapeuticsMD (TXMD) Tax Provisions (2011 - 2025)

TherapeuticsMD's (TXMD) quarterly Tax Provisions came in at -$32000.0 in Q1 2025, up 89.33% on a QoQ basis from -$300000.0 in Q3 2022.

TherapeuticsMD (TXMD) Tax Provisions (2011 - 2025) Analysis & Trends

TherapeuticsMD (TXMD) has 3 years of Tax Provisions data on file, last reported at -$32000.0 in Q1 2025.

Quarterly Tax Provisions changed N/A year-over-year to -$32000.0 in Q1 2025, while the trailing twelve-month figure through Sep 2025 was -$332000.0 (changed N/A YoY) and the FY2024 annual result came in at -$31000.0, up 27.91% from the prior year.
Tax Provisions improved to -$32000.0 in Q1 2025, from -$300000.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $550000.0 in Q2 2022 to a low of -$300000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Haleon	43.85 Bn	42.88 Bn	-	-
2	Teva Pharmaceutical Industries	43.02 Bn	39.37 Bn	2.15 Bn	121.00 Mn
3	Zoetis	31.47 Bn	29.79 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.59 Bn	22.79 Bn	5.10 Bn	-310.32 Mn
5	United Therapeutics	22.20 Bn	19.53 Bn	683.80 Mn	39.70 Mn
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn	54.80 Mn
7	Neurocrine Biosciences	15.45 Bn	15.06 Bn	935.80 Mn	17.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	2.00 Mn
9	Dr Reddys Laboratories	10.10 Bn	9.94 Bn	-	-
10	TherapeuticsMD	23.67 Mn	14.48 Mn	-	-

Download Data